Join
Live feed
·
SECFilingvia Quantisnow
Liminatus Pharma Inc. logo

Liminatus Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
LIMN· Liminatus Pharma Inc.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIMN (Liminatus Pharma Inc.) and more on Quantisnow.